Real-world effectiveness of lenvatinib monotherapy among previously treated unresectable hepatocellular carcinoma patients in United States clinical practices.

Amit G. Singal,Saurabh P. Nagar, Abigail Hitchens,Shrividya Iyer

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 0|浏览0

暂无评分

摘要

273Background: In the United States (U.S.), lenvatinib monotherapy was approved in August 2018 for first-line treatment of patients with unresectable hepatocellular carcinoma (uHCC) based on the pi...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要